-
In response to centralized procurement, pharmaceutical companies are accelerating their breakthrough in three directions
Time of Update: 2021-12-28
In recent years, under the pressure of the country's policies to encourage innovation and mass procurement, pharmaceutical companies have begun to increase R&D investment to enhance R&D capabilities and obtain more profits.
-
Medical talents are changing rapidly, and school-enterprise cooperation will blossom everywhere in the future
Time of Update: 2021-12-28
Hongri Pharmaceutical and its various sectors and subsidiaries have established talent training and employment practice bases with Tianjin Medical University, Changchun University of Traditional Chinese Medicine, Jiangsu Ocean University and many other colleges and universities for many years, and strengthened in-depth cooperation in industry, university and research .
-
This year 33 biopharmaceutical companies have landed on the Science and Technology Innovation Board, and the market value of 13 has exceeded 10 billion
Time of Update: 2021-12-28
In addition, Dizhe Pharmaceutical, an innovation-driven biomedical company that recently landed on the Science and Technology Innovation Board, has a market value of more than 10 billion yuan .
-
Kelun/and platinum jointly declare the second domestic paragraph of TSLP antibody
Time of Update: 2021-12-28
In April 2018, Hebo Pharma and Kelun Botai reached a global strategic cooperation to jointly research, develop and commercialize new fully human antibody drugs .
-
The effect is amazing!
Time of Update: 2021-12-28
Among the 252 patients with CLL/SLL who had previously received BTKi treatment and whose curative effect was assessable, 171 had a response, including 2 CR, 137 PR, 32 partial remission with persistent lymphocytosis (PR-1), 62 SD, ORR 68% .
-
FDA suspends Merck's HIV drug islatravir oral and implantable investigational new drug application
Time of Update: 2021-12-28
The study has not yet opened patient recruitment and registration;MK-8591-043 is a phase 2a PrEP trial that evaluates the efficacy of islatravir injection once a year in individuals at low risk of HIV-1 infection.
-
2 pharmaceutical companies were selected as a list of benchmarking enterprises for smart manufacturing in Yunnan Province
Time of Update: 2021-12-28
Specifically, the health industry project (Phase I) implemented by Yunnan Baiyao has built a world-leading industrial base with an annual output of 500 million toothpastes, realizing automatic scheduling of production plans, automatic control of production processes, tracking and tracing of production data throughout the entire process, and Automatic handling of materials, automatic storage and delivery of finished products, production equipment, process, control and system integration to achieve overall intelligence.
-
How fragrant is the pharmaceutical special equipment field that CDMO giants have also deployed?
Time of Update: 2021-12-28
And just recently, the domestic CDMO giant Kailaiying has also newly invested in a company with a business scope covering special pharmaceutical equipment .
According to data, the average export ratio of domestic pharmaceutical special equipment manufacturing since 2018 is only This is 9%.
-
How will Internet healthcare develop in 2022?
Time of Update: 2021-12-27
In general, although the development prospects of Internet medical care are broad, enterprises need to standardize their operations if they want to share the market.
-
The importance of scientific and technological innovation is highlighted, and the modern development of the pharmaceutical equipment industry will embark on a new journey
Time of Update: 2021-12-27
In recent years, as the "stuck neck" problem in the field of industrial economy has become more prominent, the industry has become more aware of the importance of technological innovation .
According to the industry, the current research and development of domestic pharmaceutical equipment is mainly concentrated in the low-end field, with low-level repetitive production.
-
Innovative drugs continue to usher in "soul bargaining", enterprises urgently need to change their competitive thinking
Time of Update: 2021-12-27
In addition, companies can also actively embrace internationalization, allow innovative drugs to enter the international market, and carry out large-scale international clinical research, thereby alleviating the pressure of high costs and low returns faced by companies in the domestic market.
-
The State Food and Drug Administration canceled 210 drug registration certificates and 6 medical device registration certificates
Time of Update: 2021-12-27
December 13, the State Food and Drug Administration announced that decided to cancel the certificate of registration chloramphenicol six films such as 210 drug registration certificate and Sichuan South Siegel Biotechnology Co.
-
With the high-quality development of the API industry, market concentration will accelerate
Time of Update: 2021-12-27
It is worth mentioning that in recent years, with the release of a series of favorable policies, the development of China's API industry is showing a trend of rapid increase in scale, accelerated clearance of low-end production capacity, and increasing industry concentration .
-
The continuous tightening of drug supervision is accelerating the transformation and upgrading of pharmaceutical companies
Time of Update: 2021-12-27
For pharmaceutical companies, how to better ensure the safety of medicines, standardization and healthy development has become a top priority in the context of continuous stricter supervision and promotion of the high-quality development of the pharmaceutical industry .
-
Another new Chinese medicine approved, will grab more than 1 billion drug market
Time of Update: 2021-12-27
The author was informed that in fact, in addition to the Qingchang Wenzhong tablet of Jiangsu Longfengtang of Yangtze River Pharmaceutical Group, many new Chinese medicines have also been approved this year .
-
The development of the biomedical industry is highly prosperous, and the proportion of biomedical equipment in pharmaceutical machinery companies has accelerated
Time of Update: 2021-12-27
(Image source: Pharmaceutical Network) The industry believes that under this background, in addition to the rapid growth of biological products and vaccines in the biomedical field, the prospects are impressive; the CXO industry in the innovative drug industry chain also continues to maintain a high growth trend .
-
Innovative medicine industry is entering a new era, and it is a trend for pharmaceutical companies to walk on multiple legs
Time of Update: 2021-12-27
On the whole, the innovative drug industry has ushered in rapid development, with the number of new drugs approved and the proportion of clinical trial applications reaching new highs year by year .
-
$11.7 billion!
Time of Update: 2021-12-27
For example, as early as September 2014, German industry giant Merck announced that it would acquire Aldrich Pharmaceuticals for US$17 billion in order to expand Merck’s life sciences business .
-
Challenge AstraZeneca's first new category of complement drug Aspaveli in more than ten years to obtain approval!
Time of Update: 2021-12-27
CompilenewbornOn December 15th, Apellis Pharmaceuticals and Swedish Orphan Biovitrum (SOBI) jointly announced that the European Commission has approved Aspaveli (pegcetacoplan) for the treatment of episodes of anemia after receiving complement C5 inhibitors for at least 3 months.
-
Eli Lilly's Alzheimer's disease drug donanemab will complete FDA rolling submission in 2022
Time of Update: 2021-12-27
In this phase 2 clinical trial involving 257 patients with Alzheimer's disease, 131 received Donanemab monoclonal antibody treatment developed by Eli Lilly and the remaining 126 received placebo treatment for 72 weeks .
